Breast cancer represents a significant challenge, and advancing treatment options is crucial for patients facing this disease. VIKTORIA-1 is a clinical trial aimed at evaluating a new investigational drug for patients with breast cancer.

By participating in VIKTORIA-1, patients have the opportunity to contribute to groundbreaking research that seeks to offer more effective treatments. Join researchers in advancing breast cancer treatment.

• Participants will be part of advanced breast cancer research.
• Participants will have access to a new investigational treatment.
• Participants will contribute to the development of potential future therapies.

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
• Any information that you provide will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

• Adults aged 18 years and above who are diagnosed with metastatic or locally advanced breast cancer
• Must be able to swallow oral medication tablets/capsules
• Must not have any known hypersensitivity to the study drugs or their components
• Must be able to attend study visits at the research site

This research study is taking place in several locations. To see if there is a research site near you, please see below.

Research Site: American Oncology Partners, PA
Location: 6410 Rockledge Drive #660, Bethesda MD 20817
Lead Researcher: Mark Goldstein, MD

Research Site: Redlands Hematology Oncology (Redlands, CA)
Location: 245 Terracina Blvd. Suite 208 Redlands, CA 92373
Lead Researcher: Dr. Emad Ibrahim

Research Site: South Broward Hospital District d/b/a Memorial Healthcare System
Location: Breast Cancer Center, Medical Office Centre, 1150 N. 35th Ave., Suite 170, 1st Floor, Hollywood, FL 33021
Lead Researcher: Delia Guaqueta, MD

This study has been reviewed and approved by the Advarra Institutional Review Board.